Media stories about Catasys (NASDAQ:CATS) have been trending somewhat negative this week, according to Accern Sentiment Analysis. The research group identifies positive and negative news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Catasys earned a media sentiment score of -0.12 on Accern’s scale. Accern also assigned news articles about the company an impact score of 46.8871653588711 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Catasys (CATS) traded up $0.03 during mid-day trading on Friday, reaching $4.61. 79,354 shares of the company traded hands, compared to its average volume of 58,138. The firm has a market capitalization of $73.25, a price-to-earnings ratio of -2.63 and a beta of -0.29. Catasys has a 52 week low of $3.30 and a 52 week high of $14.00.
Catasys (NASDAQ:CATS) last posted its quarterly earnings data on Tuesday, November 14th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.15) by ($0.04). analysts predict that Catasys will post -0.89 EPS for the current fiscal year.
WARNING: This story was published by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this story on another site, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this story can be viewed at https://stocknewstimes.com/2018/01/21/catasys-cats-earns-daily-media-sentiment-score-of-0-12.html.
Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The companys OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.
Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.